AD
Adaptimmune
ADAP·NASDAQAbingdon UKFounded 2008300 employees
Micro CapbiotechPublicOncology
Platform: Afami-cel TCR-T
Market Cap
$0.15B
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (ADAP)
Loading ADAP stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Capiinavolisib | ADA-8430 | Phase 2/3 | 2 | JAK2 | Narcolepsy | ||
| Terafotisoran | ADA-669 | Phase 1/2 | 1 | PI3Kα | ALSSchizophrenia |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)